Cefepime hydrochloride and Opportunistic infection - a phase IV clinical study of FDA data

Summary:

Opportunistic infection is reported only by a few people who take Cefepime Hydrochloride.

The phase IV clinical study analyzes which people take Cefepime hydrochloride and have Opportunistic infection. It is created by eHealthMe based on reports of 1,238 people who have side effects while taking Cefepime hydrochloride from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 26, 2023

1,238 people reported to have side effects when taking Cefepime hydrochloride.
Among them, 2 people (0.16%) have Opportunistic infection.

What is Cefepime hydrochloride?

Cefepime hydrochloride has active ingredients of cefepime hydrochloride. eHealthMe is studying from 1,264 Cefepime hydrochloride users for its effectiveness, alternative drugs and more.

What is Opportunistic infection?

Opportunistic infection (a microorganism that normally does not cause disease but becomes pathogenic when the body's immune system is impaired and unable to fight) is found to be associated with 706 drugs and 352 conditions by eHealthMe.

Number of Cefepime hydrochloride and Opportunistic infection reports submitted per year:

Could Cefepime hydrochloride cause Opportunistic infection?

Time on Cefepime hydrochloride when people have Opportunistic infection *:

Gender of people who have Opportunistic infection when taking Cefepime hydrochloride *:

female: 50 %
male: 50 %

Age of people who have Opportunistic infection when taking Cefepime hydrochloride *:

Common drugs people take besides Cefepime hydrochloride *:

Zometa: 1 person, 50.00%
Eurax: 1 person, 50.00%
Lomotil: 1 person, 50.00%
Linezolid: 1 person, 50.00%
Lantus: 1 person, 50.00%
Hydroxyzine: 1 person, 50.00%
Hydrocortisone Sodium Succinate: 1 person, 50.00%
Hycodan: 1 person, 50.00%
Gabapentin: 1 person, 50.00%
Fluocinonide: 1 person, 50.00%

Common side effects people have besides Opportunistic infection *:

Pneumocystis Jiroveci Pneumonia (fungal infection of the lungs): 1 person, 50.00%
Fever: 1 person, 50.00%
Blood Beta-D-Glucan Increased: 1 person, 50.00%
Blood Creatinine Increased: 1 person, 50.00%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 1 person, 50.00%
Death: 1 person, 50.00%
Drug Ineffective: 1 person, 50.00%
Febrile Neutropenia (fever with reduced white blood cells): 1 person, 50.00%
Fluid Overload (too much fluid in the blood): 1 person, 50.00%
Malaise (a feeling of general discomfort or uneasiness): 1 person, 50.00%

Common conditions people have *:

Wheezing (a high-pitched whistling sound made while you breath): 1 person, 50.00%
Itching: 1 person, 50.00%
Constipation: 1 person, 50.00%
Cough: 1 person, 50.00%
Delirium (wild excitement): 1 person, 50.00%
Depression: 1 person, 50.00%
Diabetes: 1 person, 50.00%
Diarrhea: 1 person, 50.00%
Dry Mouth: 1 person, 50.00%
Eczema Asteatotic (severe dry skin- during the winter months and in the elderly): 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Cefepime hydrochloride and have Opportunistic infection?

Check whether Opportunistic infection is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Browse all side effects of Cefepime hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Opportunistic infection treatments and more:

Opportunistic infection (2,226 reports)

COVID vaccines that are related to Opportunistic infection:

Common drugs associated with Opportunistic infection:

All the drugs that are associated with Opportunistic infection:

Opportunistic infection (706 drugs)

Common conditions associated with Opportunistic infection:

Multiple sclerosis: 596 reports
Rheumatoid arthritis: 169 reports

All the conditions that are associated with Opportunistic infection:

Opportunistic infection (352 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cefepime hydrochloride (the active ingredients of Cefepime hydrochloride) and Cefepime hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.